No prescription? No problem: A qualitative study investigating self-medication with novel psychoactive substances (NPS)

Original research
par
Holborn, Tayler, Fabrizio Schifano & Paolo Deluca

Date de publication

2023

Géographie

International

Langue de la ressource

English

Texte disponible en version intégrale

Oui

Open Access / OK to Reproduce

Oui

Évalué par des pairs

Yes

L’objectif

This study aims to investigate the occurrence of Novel Psychoactive Substances (NPS) self-medication, identify the specific NPS involved, and understand the motivations behind their use.

Constatations/points à retenir

Our study revealed frequent discussions about the self-medication with several NPS, notably etizolam, clonazolam, diclazepam, flualprazolam, 2-FMA, 4F-MPH, 3-FPM and 3-MeO-PCP. Individuals were mainly self-treating ADHD, anxiety and depression. Motivations for choosing NPS included access, cost, legality and a dissatisfaction with conventional healthcare. Substances were often chosen based on a profile of "Functionality" and outcomes varied. The use of clonazolam was highlighted as particularly problematic.

La conception ou méthodologie de recherche

Content analysis from Reddit (93 threads, 182,490 words, 5023 comments)

Mots clés

About PWUD
Mental health